Paragon Biomedical Inc.

Paragon Biomedical Inc. is a specialized service provider focused on facilitating domain acquisitions to enhance businesses' online presence through premium domains. Founded in 1989 and headquartered in Irvine, US, Paragon Biomedical Inc. specializes in domain acquisition services.

In September 2012, the company was acquired by Clinipace Worldwide, with the financial details of the transaction undisclosed. The acquisition was financed by NXT Capital's Venture Finance Group. Parabio. com specializes in providing a streamlined pricing service for domain acquisitions, catering primarily to businesses seeking to enhance their online presence through premium domain names.

Their core offering involves a comprehensive pricing inquiry process, allowing clients to receive tailored quotes from domain experts within 24 business hours. This service is aimed at companies looking to secure valuable digital real estate for branding and marketing purposes, targeting startups, established enterprises, and digital marketers across various industries. Their services are marketed primarily in the United States and Canada, as well as internationally, focusing on regions where businesses recognize the importance of a strong online identity. Parabio.

com generates revenue through a transaction-based model that emphasizes direct engagement with clients seeking domain acquisition services. The company facilitates business transactions by providing quoted prices for domain names, with inquiries often converting into purchases. The pricing structure reflects the perceived value of the domain names, influenced by market demand and keyword relevance. This B2B model enables Parabio.

com to establish partnerships with businesses aiming to acquire premium domains, thus driving revenue through individual sales and a straightforward transaction process. As of now, there is no disclosed information regarding upcoming product launches or plans for expanding into new markets or regions. The recent acquisition by Clinipace Worldwide may provide opportunities for strategic growth and synergies, although specific details regarding utilization of resources from the acquisition are not available.